Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 1584

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 7
Chunk 1584
---
 income or loss. The measure of segment assets is reported on the consolidated balance sheets as total assets. When evaluating the
Company’s performance and making key decisions regarding resource allocation the CODM reviews several key metrics, which include
the following:

    For the  Year Ended  December 31, 
    2024  
    For the  Year Ended  December 31, 
    2023 
  
    General and administrative expenses 
    $3,524,549  
    $1,830,700 
  
    Interest earned on investments held in the Trust Account 
    $1,450,228  
    $2,775,291 

The CODM reviews interest earned on the Trust
Account to measure and monitor stockholder value and determine the most effective strategy of investment with the Trust Account funds
while maintaining compliance with the trust agreement. General and administrative expenses are reviewed and monitored by the CODM to manage
and forecast cash to ensure enough capital is available to complete a business combination within the business combination period. The
CODM also reviews general and administrative costs to manage, maintain and enforce all contractual agreements to ensure costs are aligned
with all agreements and budget. General and administrative costs, as reported on the consolidated statements of operations, are the significant
segment expenses provided to the CODM on a regular basis.

All other segment items included in net income
or loss are reported on the consolidated statements of operations and described within their respective disclosures.

NOTE 10–SUBSEQUENT EVENTS 

The Company evaluated subsequent events to
determine if events or transactions occurred after the balance sheet date up to the date the consolidated financial statements were
issued. The Company did not identify any subsequent events that would have required adjustment or disclosure in the consolidated
financial statements, other than the following:

Annual Meeting of Stockholders

On February 13, 2025, the Company held a special
meeting of its stockholders (the “Special Meeting”). At the Special Meeting, the Company’s stockholders approved several
proposals to amend the Company’s Charter. The stockholders approved the business combination (the “Business Combination”)
reflected by the Amended and Restated Business Combination Agreement, dated May 23, 2024, as amended on December 20, 2024 (the “Business
Combination Agreement”). The stockholders also approved to change Bellevue Life Sciences Acquisition Corp.’s name to “OSR,
Inc.” The stockholders also approved to increase the number of shares of preferred